Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.4.0.3
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Current assets:    
Cash $ 5,762 $ 7,857
Receivables 4,857 4,213
Prepaid expenses and other current assets 370 174
Total current assets 10,989 12,244
Property and equipment, net 1,007 1,043
Total assets 11,996 13,287
Current liabilities:    
Accounts payable 4,258 4,158
Accrued clinical trials expenses 379 341
Other accrued liabilities 443 354
Total current liabilities 5,080 4,853
Warrant liabilities 1,440 1,444
Total liabilities $ 6,520 $ 6,297
Commitments and contingencies
Stockholders’ equity:    
Common stock, at amounts paid-in $ 297,828 $ 297,828
Additional paid-in capital 23,593 23,261
Accumulated deficit (315,945) (314,099)
Total stockholders’ equity 5,476 6,990
Total Liabilities and Stockholders’ Equity $ 11,996 $ 13,287